Psychedelics

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing. REGISTER OR LOGIN NOW AT: The company presentations will be available 247 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's "virtual trade booth". ...

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.

REGISTER OR LOGIN NOW AT: https://bit.ly/3acCV7Y

The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's "virtual trade booth".

Presentations

Presentation

Ticker(s)

Fireside Chat - Amy Emerson, CEO of MAPS Public Benefit Corporation

"Investing in Psychedelics and CNS Treatments"

Lindsay Hoover, Partner, JLS Fund

Dan Ahrens, PM of the Psychedelics ETF (NYSEArca: PSIL), AdvisorShares Investments

Tim Regan, SVP, KCSA Strategic Communications

Small Pharma Inc.

( Pink: DMTTF | TSX-V: DMT)

Awakn Life Sciences Corp.

( OTCQB: AWKNF | NEO: AWKN)

HMNC Brain Health

( Private Company )

Enveric Biosciences

( NASDAQ: ENVB )

Mind Cure Health Inc.

( OTCQX: MCURF | CSE: MCUR)

Field Trip Health Ltd.

( NASDAQ: FTRB | TSX: FTRP)

Novamind Inc.

( OTCQB: NVMDF | CSE: NM)

BetterLife Pharma Inc.

( OTCQB: BETRF | CSE: BETR)

MYND Life Sciences Inc.

( Pink: MYNDF | CSE: MYND)

FSD Pharma Inc.

( NASDAQ: HUGE | CSE: HUGE)

Mindset Pharma Inc.

( OTCQB: MSSTF | CSE: MSET)

PsyBio Therapeutics Corp.

( OTCQB: PSYBF | TSX-V: PSYB)

Psyched Wellness Ltd.

( OTCQB: PSYCF | CSE: PSYC)

Bright Minds Biosciences Inc.

( OTCQB: BMBIF | CSE: DRUG)

Cybin Inc.

( NYSE American: CYBN | NEO: CYBN)

Mydecine Innovations Group

( Pink: MYCOF | NEO: MYCO)

NeonMind Biosciences Inc.

( OTCQB: NMDBF | CSE: NEON)

Numinus Wellness Inc.

( TSX-V: NUMI )

Tryp Therapeutics Inc.

( OTCQB: TRYPF | CSE: TRYP)

Wesana Health Holdings Inc.

( OTCQB: WSNAF | CSE: WESA)

Filament Health Corp.

( OTCQB: FLHLF | NEO: FH)

To facilitate investor relations scheduling, please contact KCSA Strategic Communications a conference@kcsa.com .

About Virtual Investor Conferences SM
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

To learn more about VIC and view a complete calendar of events, please visit www.virtualinvestorconferences.com .

About KCSA Strategic Communications
KCSA is a fully integrated communications agency specializing in public relations, investor relations and social media, with expertise in financial and professional services, technology, healthcare, digital media and cannabis. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm's clients are its best references. For more information, please visit www.kcsa.com .

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/kcsa-psychedelics-virtual-investor-conference-presentations-available-for-on-demand-viewing-301402040.html

SOURCE VirtualInvestorConferences.com

News Provided by Canada Newswire via QuoteMedia

Psychedelics Company Silo Wellness Announces U.S. DTC Eligibility

Psychedelics Company Silo Wellness Announces U.S. DTC Eligibility

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) ("Silo Wellness" or the "Company"), a leading global psychedelics company, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States.

DTC is a subsidiary of The Depository Trust & Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly-traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered "DTC eligible." This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a wider selection of brokerage firms.

Keep reading... Show less

Seelos Therapeutics Announces Issuance of Composition of Matter Patent in Japan for SLS-007

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has received an issued patent from the Japanese Patent Office (Japanese patent number 6968839, titled: STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION), covering the composition of matter for SLS-007, a potentially disease-modifying gene therapy focused on intracellular alpha-synuclein (α-synuclein) aggregation in Parkinson's disease (PD).

Keep reading... Show less
Awakn Life Sciences to Participate at Upcoming December Conferences

Awakn Life Sciences to Participate at Upcoming December Conferences

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat Addiction, announced today that Anthony Tennyson, Chief Executive Officer, is scheduled to present at the following upcoming virtual December investor conferences.

H.C. Wainwright 2nd Annual Psychedelics Conference
Presentation: On Demand Beginning Monday, December 6th at 7:00 a.m. ET
Registration: Click here

Keep reading... Show less

Michael Falvey joins COMPASS Pathways as Chief Financial Officer

London, UK - 3 December 2021

COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has appointed Michael Falvey as Chief Financial Officer, replacing Piers Morgan when he leaves the company, as previously announced, at the end of the year.

Keep reading... Show less
Gwella logo

Gwella Mushrooms: Alternative Wellness Platform for Functional Health, Mushrooms and Psychedelics

Gwella focuses on building an accessible, original and scalable over-the-counter portfolio of functional and psychedelic mushroom products that enhance individual and community wellness. The company's advanced direct-to-consumer platform combines an innovative mix of wellness, mushrooms and psychedelics with a modern twist in an integration of media and technology.

Gwella Wellness is the company's purpose-built consumer product vertical. Using exclusive ingredients, formulations, delivery systems, testing and research, Gwella Branded CPG tackles health and wellness through high volume avenues in retail, e-commerce and clinical, retreat and legal jurisdictions. Its product pipeline includes Gwella's flagship Mojo, Journey, and incoming MYMYCO, Yugen and Anxiety Strips, with more products in development.

Keep reading... Show less
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, announced today that Robert Tessarolo, President and Chief Executive Officer, will participate in the H.C. Wainwright 2nd Annual Psychedelics Conference, being held virtually on Monday, December 6, 2021

H.C. Wainwright 2nd Annual Psychedelics Virtual Conference Details:

Keep reading... Show less

Top News

Related News